Curium's Turkish radiopharmaceuticals deal wins conditional approval
MLex Summary: Radiopharmaceutical products specialist Curium has won approval from Turkey’s competition authority to buy nuclear medicine rival Eczacıbaşı Monrol Nükleer Ürünler Sanayi ve Ticaret Anonim Şirketi. To gain the approval,...To view the full article, register now.
Already a subscriber? Click here to view full article